Are you Dr. Chen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 40 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
145 Michigan St NE
Suite 3100
Grand Rapids, MI 49503Phone+1 616-954-9800Fax+1 616-954-2116
Summary
- Dr. Yuanbin Chen, MD is an oncologist in Grand Rapids, Michigan. He is currently licensed to practice medicine in Michigan, District of Columbia, and Maryland. He is affiliated with Corewell Health - Butterworth Hospital, Trinity Health Grand Rapids Hospital, and Corewell Health Greenville Hospital.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Westchester Medical CenterResidency, Internal Medicine, 2009 - 2012
NYU Grossman School of MedicineInternship, Transitional Year, 2008 - 2009
Sun Yat-Sen University of Medical ScienceClass of 1998
Certifications & Licensure
MI State Medical License 2014 - 2027
DC State Medical License 2014 - 2014
MD State Medical License 2012 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 222 citationsNeoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.Sapna P Patel, Megan Othus, Yuanbin Chen, G Paul Wright Jr, Kathleen J Yost
The New England Journal of Medicine. 2023-03-02 - 129 citationsSotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASmutation: a randomised, open-label, phase 3 trial.Adrianus Johannes de Langen, Melissa L Johnson, Julien Mazieres, Anne-Marie C Dingemans, Giannis Mountzios
Lancet. 2023-03-04 - 322 citationsDurvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CA...Jonathan W. Goldman, Mikhail Dvorkin, Y. Chen, Niels Reinmuth, Katsuyuki Hotta
The Lancet. Oncology. 2021-01-01
Press Mentions
Neoadjuvant Immunotherapy Improves Outlook in High-Risk MelanomaFebruary 24th, 2023- Neoadjuvant Immunotherapy Improves Outlook in High-Risk MelanomaSeptember 11th, 2022
- Yuanbin Chen, M.D., PhD. – Cancer & Hematology Centers of Western Michigan, PCMay 14th, 2021
- Join now to see all
